Concepedia

Jo Raskin

JR

Statistics

Publications

15

Citations

1.4K

H-Index

12

Active since

2017

Affiliations

Antwerp University Hospital(Current)

The University of Texas MD Anderson Cancer Center

Guangdong Academy of Medical Sciences

KU Leuven

Merck KGaA, Darmstadt (Germany)

Jo Raskin is an author at Antwerp University Hospital specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2017–2024

15

Publications

15

Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations

Paul K. Paik, Enriqueta Felip, Rémi Veillon et al. · New England Journal of Medicine · 2020 · 854 citations · Full text

, , +15

Tepotinib Treatment in Patients With <i>MET</i> Exon 14–Skipping Non–Small Cell Lung Cancer

Julien Mazières, Paul K. Paik, Marina Chiara Garassino et al. · JAMA Oncology · 2023 · 94 citations · Full text

, , +13

Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial

Yi‐Long Wu, Valentina Guarneri, Pei Jye Voon et al. · The Lancet Oncology · 2024 · 86 citations · Full text

, , +16

Mortality after lung transplantation: a single‐centre cohort analysis

Jo Raskin, Arno Vanstapel, Eric Verbeken et al. · Transplant International · 2019 · 62 citations · Full text

, , +12

The art of obtaining a high yield of cell-free DNA from urine

Elien Augustus, Kaat Van Casteren, Laure Sorber et al. · PLoS ONE · 2020 · 59 citations · Full text

, , +14

1–5 of 15